Delivery Order SPE2DB20D6037-SPE2DB23FD0RU

Award Date 8/18/23
Potential Completion Date 8/21/23
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $18,790.20 firm fixed-price delivery order contract is for the supply of Atovaquone-Proguanil 250-100 mg tablets, to support the medical needs of military health facilities. The award is part of a larger $4,999,999 indefinite delivery vehicle (IDV) contract that DMS Pharmaceutical Group holds with DLA,...
The U.S. government's Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,390.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of ATOVAQUONE/PROGUANIL, a pharmaceutical product, and does not have a set-aside designation. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,396.19 award is for the supply of ATOVAQUONE/PROGUANIL, a pharmaceutical product, to support the medical needs of military personnel. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program....
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,314.00 contract is for the delivery of Atovaquone-Proguanil 250-100 mg tablets, a malaria treatment medication, with a completion date of January 26, 2024. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract...
This federal contract award SPE2DX15D9903|SPE2DX24FASKZ was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,513.23 firm fixed-price delivery order is for the provision of 4564930044! ATOVAQUONE/PROGUANIL, a pharmaceutical product, with a completion date of May 23, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This is a Delivery Order issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,332.80 Firm Fixed Price contract is for the delivery of Atovaquone 250mg/Proguanil HCl 100mg tablets, with a period of performance through June 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $499,999,999 that DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,499.52 contract is for the delivery of 4558986658 - ATOVAQUONE-PROGUANIL 250-100 100S, a specialized pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA, which covers a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,067.00 and has a completion date of June 26, 2024. DMS Pharmaceutical Group will supply the DLA with 4564993076 units of Atovaquone-Proguanil 250-100mg tablets. This delivery order is issued under a larger indefinite delivery...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,396.19, is a delivery order under the Defense Logistics Agency (DLA) SPE2DX24FASMA program. The contract is for the delivery of ATOVAQUONE/PROGUANIL, a pharmaceutical product, to support the medical supply needs of the Department of Defense (DoD). The contract has a firm fixed-price pricing type and a completion date...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of Atovaquone-Proguanil 250-100mg tablets. The contract has a completion date of February 14, 2024 and a potential value of $1,929.20. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDV) 4600082013 with the Defense Logistics Agency, valued at up to...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB23FD0RU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,640.08 firm fixed-price delivery order is for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a vast array of pharmaceutical products, from common medications to specialized drugs and medical supplies, in support of Department of Defense healthcare facilities globally. The contract does not have a set-aside designation.

Generated 10/23/24, 9:27 AM